Cite

MLA Citation

    Melody Qu et al.. “92 Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of SABR-COMET.” Radiotherapy and oncology, vol. 139, n.d., pp. S41–S42. http://access.bl.uk/ark:/81055/vdc_100094430725.0x000043
  
Back to record